PT828733E - Benzopiranos e composicoes farmaceuticas que os contem - Google Patents

Benzopiranos e composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT828733E
PT828733E PT96917431T PT96917431T PT828733E PT 828733 E PT828733 E PT 828733E PT 96917431 T PT96917431 T PT 96917431T PT 96917431 T PT96917431 T PT 96917431T PT 828733 E PT828733 E PT 828733E
Authority
PT
Portugal
Prior art keywords
benzopyran
dihydro
dimethyl
hydroxy
oxo
Prior art date
Application number
PT96917431T
Other languages
English (en)
Portuguese (pt)
Inventor
Paul W Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT828733(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT828733E publication Critical patent/PT828733E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96917431T 1995-05-24 1996-05-24 Benzopiranos e composicoes farmaceuticas que os contem PT828733E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
PT828733E true PT828733E (pt) 2002-02-28

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96917431T PT828733E (pt) 1995-05-24 1996-05-24 Benzopiranos e composicoes farmaceuticas que os contem

Country Status (31)

Country Link
US (1) US5905156A (xx)
EP (1) EP0828733B1 (xx)
JP (1) JPH11505820A (xx)
KR (1) KR100437981B1 (xx)
CN (1) CN1077888C (xx)
AR (1) AR004489A1 (xx)
AT (1) ATE205204T1 (xx)
AU (1) AU703276B2 (xx)
BR (1) BR9609048A (xx)
CA (1) CA2217821C (xx)
CO (1) CO4700520A1 (xx)
CZ (1) CZ294474B6 (xx)
DE (1) DE69615019T2 (xx)
DK (1) DK0828733T3 (xx)
ES (1) ES2163634T3 (xx)
FI (1) FI973992A (xx)
GB (1) GB9510477D0 (xx)
HK (1) HK1014137A1 (xx)
HU (1) HU222772B1 (xx)
IL (1) IL118382A (xx)
MY (1) MY114924A (xx)
NO (1) NO314846B1 (xx)
NZ (1) NZ309765A (xx)
PL (1) PL184144B1 (xx)
PT (1) PT828733E (xx)
RU (1) RU2160735C2 (xx)
SK (1) SK283215B6 (xx)
TR (1) TR199701417T1 (xx)
TW (1) TW421646B (xx)
WO (1) WO1996037490A1 (xx)
ZA (1) ZA964209B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
US7098340B2 (en) 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
KR20180067561A (ko) 2015-09-28 2018-06-20 제넨테크, 인크. 치료 화합물 및 그의 사용 방법
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) 2017-03-24 2020-04-16 ジェネンテック， インコーポレイテッド ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (xx) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
EP0828733B1 (en) 2001-09-05
HU222772B1 (hu) 2003-10-28
ATE205204T1 (de) 2001-09-15
DE69615019T2 (de) 2002-06-06
CO4700520A1 (es) 1998-12-29
JPH11505820A (ja) 1999-05-25
KR19990021925A (ko) 1999-03-25
CA2217821A1 (en) 1996-11-28
BR9609048A (pt) 1999-02-23
IL118382A0 (en) 1996-09-12
DE69615019D1 (de) 2001-10-11
ZA964209B (en) 1997-11-24
HUP9801751A3 (en) 1999-08-30
GB9510477D0 (en) 1995-07-19
CN1077888C (zh) 2002-01-16
US5905156A (en) 1999-05-18
NO975365D0 (no) 1997-11-21
NO314846B1 (no) 2003-06-02
AR004489A1 (es) 1998-12-16
TW421646B (en) 2001-02-11
HK1014137A1 (en) 1999-09-24
EP0828733A1 (en) 1998-03-18
PL184144B1 (pl) 2002-09-30
NO975365L (no) 1998-01-15
DK0828733T3 (da) 2001-12-17
ES2163634T3 (es) 2002-02-01
KR100437981B1 (ko) 2004-07-16
IL118382A (en) 2000-01-31
NZ309765A (en) 2000-01-28
TR199701417T1 (xx) 1998-02-21
AU703276B2 (en) 1999-03-25
CN1185153A (zh) 1998-06-17
WO1996037490A1 (en) 1996-11-28
CA2217821C (en) 2008-05-06
FI973992A0 (fi) 1997-10-17
AU6000896A (en) 1996-12-11
FI973992A (fi) 1997-12-09
CZ368897A3 (cs) 1998-02-18
SK283215B6 (sk) 2003-03-04
MY114924A (en) 2003-02-28
PL324042A1 (en) 1998-05-11
HUP9801751A2 (hu) 1999-06-28
RU2160735C2 (ru) 2000-12-20
SK157797A3 (en) 1998-05-06
CZ294474B6 (cs) 2005-01-12
MX9709004A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
PT99775B (pt) Processo para a preparacao de novos derivados de di-hidroisoquinolina
DK169337B1 (da) Xanthinforbindelser, farmaceutisk præparat indeholdende disse, xanthinforbindelser til anvendelse som et farmaceutisk middel samt fremgangsmåde til fremstilling af forbindelserne
US4980359A (en) Isoquinoline derivatives and their use
PT828733E (pt) Benzopiranos e composicoes farmaceuticas que os contem
HU203234B (en) Process for producing new, multiply oxygenated labdane derivatives and pharmaceutical compositions comprising such compounds as active ingredient
JPH0730072B2 (ja) 置換３，４‐ジヒドロ‐２ｈ‐ベンゾピラン
US4818772A (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes: methods of synthesis and utilization as medicines
US5574049A (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
AU621388B2 (en) The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
WO1994012493A1 (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
US5849745A (en) N-benzylpiperazine compounds
MXPA97009004A (en) Benzopira
AU665040B2 (en) 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
NL8004002A (nl) Chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen.
RU2104277C1 (ru) 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран
WO2000021957A1 (en) Benzopyrans having potassium channel opening activity
NZ245321A (en) Substituted 6-(pyridin-4-yl)-2h-1-benzopyran derivatives and pharmaceutical compositions thereof
JP2583028B2 (ja) ２，２−ジアルキル−および２，２−ジアルキル−３，４−ジヒドロ−３−ヒドロキシ−−２ｈ−１−ベンゾピラン類
CZ282091B6 (cs) 2,2-Dialkyl-2H-1-benzopyrany a 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrany
JP2625094B2 (ja) 抗血小板・抗血栓剤
PL172371B1 (pl) Sposób wytwarzania 2,2-diaikilo- i 2,2-dialkilo-3,4- dihydro-3-hydroksy-2H-1-benzopiranów PL
JPH04226977A (ja) ベンゾピラン誘導体およびその製造法